First patients in IBD trial
GCT announces first subjects screened in the Russian part of a multinational ulcerative colitis trial. Locally, the study is conducted in 6 investigative sites on behalf of a US Sponsor developing an innovative biologic product to treat this debilitating condition.
Updated: March 17, 2017
Permanent link: https://2022.gctrials.com/news/first-patients-in-ibd-trial/